IBSA Institut Biochimique SA
IBSA Group is a multinational pharmaceutical company headquartered in Lugano, Switzerland
The production facilities and R&D labs are distributed in Switzerland, Italy and China.
IBSA operates in more than 90 countries and 5 continents with 16 subsidiaries in Europe, China and the USA, and employs around 2,000 people distributed among our headquarters, subsidiaries and manufacturing plants.
IBSA holds 90 patent families and many others in development, with a diversified portfolio covering 10 different therapeutic areas.
It is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products.
IBSA has 4 pillars:
News

28.06.2022
“#IBSA2030. Your Future, Our Mission” – the project to tell the journey towards sustainability – abo ...

23.06.2022
IBSA at the EAU 2022: commitment, impact and innovation in the urogynecological field

16.06.2022
Equitable sport always wins: 3rd place for the Camaleonti (“Chameleons”) at the international inclus ...

13.06.2022
Sport, science and health: the perfect synergy introduced by IBSA at Isokinetic 2022

08.06.2022
IBSA in Person – Worldwide: the storytelling of IBSA’s subsidiaries begins

02.06.2022
Innovation, technology and attention to the Person in the new department of single-dose strips

26.05.2022
The importance of trusting relationships: IBSA’s distributors in South Korea and Jordan

19.05.2022
Inclusive sailing, an essential part of the project ‘Sailing into the Future. Together’

12.05.2022